Florida Board of Medicine Marketing Rules · 2026 Playbook for FL Physicians and Clinic Marketers

By Santosh Reddy · Director, Ichelon Consulting US

Reviewed by Hanuman Sihag, Head of Innovation Chamber — SEO & AIO

LinkedIn

The FBM framework — 64B8 F.A.C.

The Florida Board of Medicine regulates physician advertising primarily through Chapter 64B8 of the Florida Administrative Code. Physician-advertising rules are addressed in 64B8-11 and adjacent provisions. Office-based surgery registration and standards live in 64B8-9. Corporate-practice and clinic-establishment rules live in Chapter 458 of the Florida Statutes and adjacent code sections. FBM enforcement operates through a disciplinary process that can impose sanctions from confidential letters of correction through licence suspension and revocation, and disciplinary action is public and searchable.

Advertising rules — truthful, not deceptive, disclosure

The operating rule under 64B8 is that physician advertising must be truthful, not deceptive, must disclose material information required for the audience to make an informed decision, and must not create unjustified expectations of results. Superlative claims without substantiation, comparative claims against unnamed competitors without support, and outcome claims that exceed the physician's actual outcome data all sit inside the risk surface. The Florida standard is stricter on cosmetic-surgery advertising specifically than on other physician advertising, reflecting the post-BBL regulatory context.

Board-certification disclosure requires accurate identification of the specific certifying body. ABMS and AOA member boards are recognised without further qualification; non-ABMS-and-non-AOA bodies require disclosure where the audience might infer ABMS-equivalent recognition. Practices should disclose the specific certifying body by name at every credential mention.

Post-BBL safety regulatory context (2019-2024) and cosmetic advertising

Between 2015 and 2020 Florida experienced a public-health-visible spike in BBL (gluteal fat grafting) mortality that led the Florida Board of Medicine to implement a series of emergency and subsequent codified rules. The framework now includes: office-based-surgery registration requirements specific to gluteal fat grafting; a mandatory technique constraint requiring subcutaneous-only injection with a prohibition on intramuscular injection; volume-per-procedure caps limiting the total fat volume injected per procedure; ultrasound-guidance requirements in specific settings; and heightened Board advertising scrutiny on BBL-specific creative.

Marketing implications for FL cosmetic-surgery practices: BBL creative must not overstate safety, must not overstate expected outcome, must accurately reflect the surgeon's technique (subcutaneous injection only under current rules), and must not imply "faster recovery" or "no downtime" for a procedure that carries real recovery requirements. Post-2024 the framework has stabilised but Board action against unsafe-technique claims and misleading recovery-time messaging continues. Ichelon Consulting US's Florida cosmetic-surgery creative pipeline scopes every BBL asset to the current FBM standard and re-reviews on a quarterly cadence.

Board-certification and testimonial rules

Testimonials require actual-patient origin, signed HIPAA marketing authorisation, and material-connection disclosure under parallel FTC endorsement rules where compensation or in-kind benefit was involved. Solicited testimonials with compensation must include a conspicuous disclosure. Board-certification claims require accurate certifying-body disclosure as described above.

Before-and-after imagery rules

Before-and-after imagery is allowed with signed patient consent, representative-results framing, and truthful-not-misleading positioning. Florida's post-BBL safety context has increased Board scrutiny on cosmetic-surgery before-and-after imagery. Imagery that overstates outcome, uses lighting manipulation between images, or presents non-representative results faces enhanced attention. Meta ad-policy rules run in parallel and are typically stricter still on cosmetic-surgery presentation.

Office-based surgery registration and marketing implications

Under 64B8-9 and related provisions, physicians performing office-based surgery in Florida (Level II and Level III procedures — including cosmetic surgery, gluteal fat grafting, breast augmentation, abdominoplasty, and other higher-risk office procedures) must register the office with the Board of Medicine, meet specific facility and equipment standards, and comply with volume-per-procedure caps for higher-risk procedures. Marketing for office-based surgery must accurately reflect registration status. Unregistered practice or false representation of registration status can trigger enhanced enforcement action, and marketing that implies capabilities the office is not registered to perform is a specific compliance risk.

Telehealth marketing rules

Telehealth practice in Florida is regulated under Florida Statutes Chapter 456 (specifically 456.47) and Board of Medicine rules on standards of care. A Florida resident cannot receive telehealth care from a physician not licensed in Florida (with limited exceptions for out-of-state physician consultations at the request of a Florida-licensed physician). Cross-state telehealth marketing that targets Florida residents from a non-Florida-licensed practice is practice-of-medicine risk. Multi-state telehealth practices marketing to Florida residents must maintain Florida licensure or scope the Florida advertising to services that do not require Florida licensure.

FBM disciplinary action patterns

FBM disciplinary actions related to advertising cluster in recurring patterns: BBL and cosmetic-surgery outcome-overstatement, credential misrepresentation, unjustified-expectation creation in aesthetic imagery, office-based-surgery-registration misrepresentation, testimonial-related violations, and post-2020 an increased pattern of enforcement against clinics running social-media influencer content without adequate Board-safe review. Practices operating in Florida should audit marketing against each of these enforcement patterns as a standard compliance step.

Related insights

Adjacent compliance pillars: HIPAA Marketing Compliance for US Clinics 2026 for the federal privacy rule set, and Healthcare Marketing Agency in Florida for statewide delivery framing. Metro-specific playbooks at Plastic Surgery Marketing Agency in Miami and Dermatology Marketing Agency in Miami.